OptiMedica

OptiMedica Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Exclusively focused in the cataract therapeutic area, the company previously developed and commercialized the PASCAL (PAttern SCAn Laser) Method of retinal photocagulation (sold to Topcon Corp. in August 2010). Founded in 2004, OptiMedica is headquartered in Santa Clara, Calif., with international offices in Singapore. The company is funded by Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital.